Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter April 2016

News: Chinese Scientists Defy Ethics, Double Down on Editing Human Embryos
In April of 2015, Chinese researchers announced to the world that they had used the new genome-editing technology CRISPR/Cas9 on human preimplantation embryos to modify the HBB gene, mutations of which have been implicated in the disease β-thalassemia. The news had sparked a media firestorm and eventually led scientists from across the globe to discuss intently the ethics of such studies, ultimately leading to the decision for an international moratorium on the use of CRISPR with human embryos.

News: EU Regulatory Panel Recommends Approval Of Glaxo's Gene Therapy For Bubble Boy Disease
An EU regulatory panel has recommended the approval of a gene therapy from GlaxoSmithKline (GSK) for the treatment of Bubble Boy Disease. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), together with the Committee for Advanced Therapies (CAT) issued a positive opinion last April 1 with regards to marketing the drug called Strimvelis for the treatment of ADA-SCID (Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency).

Conference: Gene Therapy Bioproduction
CHI’s Gene Therapy Bioproduction meeting (August 18-19, 2016) in Boston takes a practical, case-study driven approach to the scale-up, quality control and analysis of gene therapies, tackling key topics such as AAV and lentivirus process development and scale-up, assay development and validation, and CMO management from early to late-stage development. Register now with code 'GENE 100' and receive a discount of $100.

- 15 April 2016, Annual conference of the British Society for Gene and Cell Therapy (BSGCT), London, UK
- 20 - 22 April 2016, ESGCT Spring School,Hannover, Germany
- 20 - 22 April 2016, World Orphan Drug Congress USA 2016, New York, NY
- 4 - 7 May 2016, American Society of Gene and Cell Therapy (ASGCT) 19th Annual Meeting, Washington, DC
- 19 – 21 May 2016, 5th International Conference and Exhibition on Cell & Gene Therapy, San Antonio, USA
- 25 - 28 May 2016, International Society for Cellular Therapy (ISCT) 22th Annual Meeting, Singapore
- 2 - 3 June 2016, Bioprocessing of Advanced Cellular Therapies Congress, London, UK
- 29 - 30 June 2016, Adoptive T Cell Therapy Congress, Boston, MA
- 28 – 30 July 2016, The 22th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan
- 18 – 19 August 2016, Gene Therapy Bioproduction conference, Boston, MA
- 14 -16 September 2016, 22th Annual Meeting of the German Society for Gene Therapy (DG-GT e.V.), Heidelberg, Germany
- 5 – 7 October 2016, Cell & Gene Therapy BioProcessing & Commercialization meeting, Boston, MA
- 18 – 21 October 2016, XXIV Congress of the European Society of Gene and Cell Therapy (ESGCT) and the International Society for Stem Cell Research, Florence, Italy
- 16 – 18 November 2016, 15th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases, Sonoma, California
- 16 - 17 March 2017, Spring Symposium of the Netherlands Society of Gene & Cell Therapy (NVGCT), Lunteren, The Netherlands
- 10 - 13 May 2017, American Society of Gene and Cell Therapy (ASGCT) 20th Annual Meeting, Washington, DC
- 27 - 28 November 2017, 19th International Conference on Cell and Gene Therapy - ICCGT 2017, Istanbul, Turkey


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?